886
R. Pirisino et al
Methylamine and benzylamine-induced hypophagia in mice
BUFFONI, F. (1995). Semicarbazide-sensitive amine oxidases: some
biochemical properties and general considerations. Prog. Brain
Res., 106, 323 ± 331.
HRNJEZ, B.J., SONG, J.C., PRASAD, M., MAYOL, J.M. & MATTHEWS,
J.B. (1999). Ammonia blockade of intestinal epithelial K+
conductance. Am. J. Physiol., 277, G521 ± G532.
BUFFONI, F., BERTINI, V. & DINI, G. (1998). The mechanism of
inhibition of benzylamine oxidase by 3,5-diethoxy-4-amino-
methylpyridine (B24). J. Enzyme Inhibition, 13, 253 ± 266.
BUTTERWORTH, R.F. (1992). Pathogenesis, and treatment of portal-
systemic encephalopathy: an update. Dig. Dis. Sci., 37, 321 ± 327.
HU, S.H., WANG, S., GIBSON, J. & GILBERTSON, T.A. (1998).
Inhibition of delayed recti®er K+channels by dexfen¯uramine
(Redux). J. Pharmacol. Exp. Ther., 287, 480 ± 486.
INUI, A. (2000). Transgenic approach to the study of body weight
regulation. Pharmacol. Rev., 52, 35 ± 61.
CASTILLO, V., LIZCANO, J.M., VISA, J.
&
UNZETA, M. (1998).
LEWINSON, R., BOHM, H.K., GLOVER, V. & SANDLER, M. (1978). A
benzylamine oxidase distinct from monoamine oxidase B.
Widespread distribution in man and rat. Biochem. Pharmacol.,
27, 1857 ± 1863.
Semicarbazide-sensitive amine oxidase (SSAO) from human and
bovine cerebrovascular tissues: biochemical and immunohisto-
logical characterization. Neurochem. Int., 33, 415 ± 423.
CHANDY, K.G., WILLIAMS, C.B., SPENCER, R.H., AGUILAR, B.A.,
LYLES, G.A. & MCDOUGALL, S.A. (1989). The enhanced daily
GHANSHANI, S., TEMPEL, B.L.
&
GUTMAN, G.A. (1990). A
excretion of urinary methylamine in rats treated with semicarba-
zide or hydralazin may be related to the inhibition of
semicarbazide-sensitive amine oxidase activities. J. Pharm.
Pharmacol., 41, 97 ± 100.
family of three mouse potassium channel genes with intronless
coding regions. Science, 247, 973 ± 975.
CHEN, X.H., ADAMS, J.U., GELLER, E.B., DERIEL, J.K., ADLER,
M.W. & LIU-CHEN, L.Y. (1995). An antisense oligodeoxynucleo-
tide to m-opioid inhibits m-opioid receptor agonist-induced
analgesia in rats. Eur. J. Pharmacol., 275, 105 ± 108.
COOK, N.S. (1988). The pharmacology of potassium channels and
their therapeutic potential. Trends Pharmacol. Sci., 9, 21 ± 28.
DAR, M.S., MORSELLI, P.L. & BOWMAN, E.R. (1985). The enzymatic
systems involved in the mammalian metabolism of methylamine.
Gen. Pharmacol., 16, 557 ± 560.
MESZAROS, Z., SZOMBATHY, T., RAIMONDI, L., KARADI, I.,
ROMICS, L. & MAGYAR, K. (1999). Elevated serum semicarba-
zide-sensitive amine oxidase activity in non-insulin-dependent
diabetes mellitus: correlation with body mass index and serum
triglyceride. Metabolism, 48, 113 ± 117.
MIYATA, G., MEGUID, M.M., FETISSOV, S.O., TORELLI, G.F. & KIM,
H.J. (1999). Nicotine's eect on hypothalamic neurotransmitters
and appetite regulation. Surgery, 126, 255 ± 263.
DAWSON, L.A. & ROUTLEDGE, C. (1995). Dierential eects of
potassium channel blockers on extracellular concentrations of
dopamine and 5-HT in the striatum of conscious rats. Br. J.
Pharmacol., 116, 3260 ± 3264.
EDWARDS, G. & WESTON, A.H. (1993). The pharmacology of ATP-
sensitive potassium channels. Annu. Rev. Pharmacol. Toxicol.,
33, 597 ± 637.
MUNDORF, M.L., HOCHSTETLER, S.E. & WIGHTMAN, R.M. (1999).
Amine weak bases disrupt vesicular storage and promote
exocytosis in chroman cells. J. Neurochem., 73, 2397 ± 2405.
PARADA, M.A., HERNANDEZ, L., SHWARTZ, D. & HOEBEL, B.G.
(1988). Hypothalamic infusions of amphetamine increase ser-
otonin, dopamin and norepinephrine. Physiol. Behav., 44, 607 ±
610.
EKBLOM, J. (1998). Potential therapeutic value of drugs inhibiting
semicarbazide-sensitive amine oxidase: vascular cytoprotection
in diabetes mellitus. Pharmacol. Res., 37, 87 ± 92.
FINNEGAN, T.K., IRWIN, I., DELANNEY, L.E. & LANGSTON, W.
(1995). Age-dependent eects of the 2'-methyl analog of 1-
methyl-4-phenyl-1,2,3,6-tetrahydropyridine: prevention by inhi-
bitors of monoamine oxidase B. J. Pharmacol. Exp. Ther., 237,
716 ± 720.
GALEOTTI, N., GHELARDINI, C., CAPACCIOLI, S., QUATTRONE, A.,
NICOLIN, A. & BARTOLINI, A. (1997). Blockade of clomipramine
and amitriptyline analgesia by an antisense oligonucleotide to
mKv1.1, a mouse Shaker-like K+channel. Eur. J. Pharmacol.,
330, 15 ± 25.
PIRISINO, R., BANCHELLI, G., IGNESTI, G., MANTELLI, L.,
MATUCCI, R., RAIMONDI, L. & BUFFONI, F. (1993). Calcium
modulatory properties of 2,6-dibutylbenzylamine (B25) in rat
isolated vas deferens, cardiac and smooth muscle preparations.
Br. J. Pharmacol., 109, 1038 ± 1045.
PRECIOUS, E., GUNN, C.E. & LYLES, G.A. (1988). Deamination of
methylamine by semicarbazide-sensitive amine oxidase in human
umbilical artery and rat aorta. Biochem. Pharmacol., 37, 707 ±
713.
QUATTRONE, A., PAPUCCI, L., SCHIAVONE, N., MINI, E.
&
CAPACCIOLI, S. (1994). Intracellular enhancement of intact
antisense oligonucleotide steady-state levels by cationic lipids.
Anticancer Drug Des., 9, 549 ± 553.
GHELARDINI, C., GALEOTTI, N., PECORI, V.A., CAPACCIOLI, S.,
QUATTRONE, A. & BARTOLINI, A. (1997). Eect of K+channel
modulation on mouse feeding behaviour. Eur. J. Pharmacol.,
329, 1 ± 8.
SIMENOFF, M.L. (1975). Metabolism and toxicity of aliphatic
amines. Kidney Int., 7, S314 ± S317.
SNYDERS, D.J. (1999). Structure and function of cardiac potassium
channels. Cardiovasc. Res., 42, 377 ± 390.
HALEY, T.J. & MCCORMICK, G.L. (1957). Pharmacological eects
produced by intracerebral injections of drugs in the conscious
mouse. Br. J. Pharmacol. Chemother., 12, 12 ± 15.
YU, P.H. & ZUO, D.M. (1993). Oxidative deamination of methylamine
by semicarbazide-sensitive amine oxidase leads to cytotoxic
damage in endothelial cells. Possible consequences for diabetes.
Diabetes, 42, 594 ± 603.
YU, P.H. & ZUO, D.M. (1997). Aminoguanidine inhibits semicarba-
zide-sensitive amine oxidase activity: implications for advanced
glycation and diabetic complications. Diabetologia, 40, 1243 ±
1250.
HALLIWELL, J.V. (1990). K+ channels in the central nervous system.
In: Potassium channels: Structure, classi®cation, function and
therapeutic potential. ed. Cook, N. S. pp. 348 ± 381. Chichester:
Ellis Horwood Limited.
HAMMES, H.P., BROWNLEE, M., EDELSTEIN, D., SALECK, M.,
MARTIN, S. & FEDERLIN, K. (1994). Aminoguanidine inhibits
the development of accelerated diabetic retinopathy in the
spontaneous hypertensive rat. Diabetologia, 37, 32 ± 35.
ZEISEL, S.H. & DACOSTA, K.A. (1986). Increase in human exposure
to methylamine precursors of N-nitrosamines after eating ®sh.
Cancer Res., 46, 6136 ± 6138.
HOPKINS, W.F.
& TEMPEL, B.L. (1992). Members of a mouse
subfamily of genes encoding voltage-gated potassium channel
subunits from heteromultimers when co expressed in Venous
oocytes. Soc. Neurosci. Abstr., 18, 1093.
(Received April 19, 2001
Revised July 23, 2001
Accepted August 3, 2001)
British Journal of Pharmacology vol 134 (4)